Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis
- 17 October 2001
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 432 (1) , 79-89
- https://doi.org/10.1016/s0014-2999(01)01427-3
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusionBritish Journal of Pharmacology, 2001
- Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paperGut, 2000
- Endoscopic and histological healing with infliximab anti–tumor necrosis factor antibodies in Crohn's disease: A European multicenter trialGastroenterology, 1999
- Antitumor Necrosis Factor Therapy for Inflammatory Bowel Disease: A Review of Agents, Pharmacology, Clinical Results, and SafetyInflammatory Bowel Diseases, 1999
- Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitisPublished by Elsevier ,1999
- Specificity of leukocyte-endothelial interactions and diapedesis: physiologic and therapeutic implications of an active decision processResearch in Immunology, 1993
- Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.Proceedings of the National Academy of Sciences, 1990
- Value of Indium-111 Granulocyte Scintigraphy in the Assessment of Crohn’s Disease of the Small Intestine: Prospective InvestigationDigestion, 1988
- The scavenging of oxidants by sulphasalazine and its metabolitesBiochemical Pharmacology, 1987
- 5-Aminosalicylate: Oxidation by activated leukocytes and protection of cultured cells from oxidative damageBiochemical Pharmacology, 1987